Extract from M&A Insights

M&A Insights is our fully-fledged M&A platform for teams operating in the Nordics and DACH countries, enabling clients to identify and qualify opportunities well in advance of any structured process.
Nordic Capital sells its remaining shares in global medical products and technology company ConvaTec
May 3, 2018

Nordic Capital has sold its remaining shares in ConvaTec Group Plc. The remaining shareholding of 143,158,828 ordinary shares (representing approximately 7.3% of the issued share capital) in ConvaTec was sold on May 3, 2018, through a book-building process which generated strong investor interest. The price was 220 pence per ordinary share, raising gross proceeds of GBP 315 million.

ⓘ This story was originally featured in our daily M&A Newsletter - a part of M&A Insights.